Chronic Thromboembolic Disease VQ Scan
Understand Chronic Thromboembolic Disease VQ Scan in Lungs (pulmonary arteries) V/Q Scan imaging, what it means, and next steps.
30-Second Overview
Persistent perfusion defects that don't resolve after anticoagulation. May show mosaic perfusion pattern, wedge-shaped defects at clot sites, and evidence of pulmonary hypertension with enlarged central arteries.
VQ scan identifies patients with chronic thromboembolic pulmonary hypertension (CTEPH), a potentially surgically curable condition. Differentiates chronic PE from acute PE and helps determine surgical candidacy for pulmonary thromboendarterectomy.
benignRate
followUp
Imaging Appearance
V/Q Scan FindingPersistent perfusion defects that don't resolve after anticoagulation. May show mosaic perfusion pattern, wedge-shaped defects at clot sites, and evidence of pulmonary hypertension with enlarged central arteries.
Clinical Significance
VQ scan identifies patients with chronic thromboembolic pulmonary hypertension (CTEPH), a potentially surgically curable condition. Differentiates chronic PE from acute PE and helps determine surgical candidacy for pulmonary thromboendarterectomy.
Understanding Chronic Thromboembolic Disease VQ Scan
Chronic thromboembolic pulmonary hypertension (CTEPH) results from failure of acute pulmonary emboli to resolve completely. Instead, the clots organize and fibrose, becoming permanent obstructions in pulmonary arteries. This leads to pulmonary hypertension, right heart failure, and progressive dyspnea.
Unlike acute PE which requires immediate anticoagulation, CTEPH may be surgically curable through pulmonary thromboendarterectomy (PTE)—a complex operation to remove chronic organized thrombi from pulmonary arteries.
Persistent perfusion defects with mosaic pattern, often asymmetric and non-segmental, strongly suggests chronic thromboembolic disease potentially amenable to surgical cure
The Evolution from Acute to Chronic
The transition from acute PE to CTEPH occurs over months:
- Acute PE (weeks 0-3): Clots are fresh and may resolve with anticoagulation
- Organization (3-12 months): Clots become organized and fibrotic
- Chronic phase (＞12 months): Permanent vascular obstructions develop
- Pulmonary hypertension: Increased resistance leads to right ventricular hypertrophy and potential failure
VQ scan at each stage shows different patterns and helps guide management decisions.
Why VQ Scan Is Essential
VQ scan provides critical information:
- Identify chronic thromboembolic disease: Distinguish from acute PE
- Assess surgical candidacy: Determine if clots are surgically accessible
- Plan surgical approach: Map clot distribution for the surgeon
- Monitor postoperative results: Assess improvement after PTE surgery
- Guide medical therapy: Evaluate response to pulmonary vasodilators
Combined with CT pulmonary angiography, accuracy exceeds 95%
Correctly rules out healthy patients
Annual new cases
Imaging Patterns
VQ Scan Findings
Chronic thromboembolic disease typically shows:
- Persistent perfusion defects: Stable over time despite anticoagulation
- Mosaic perfusion pattern: Patchy areas of both increased and decreased uptake
- Non-segmental defects: Don't follow anatomical lung segment boundaries
- Wedge-shaped defects: Peripheral, often at sites of previous PE
- Asymmetric distribution: Often more severe in one lung
Comparison with Acute PE
Acute PE shows:
- Suddenly appearing perfusion defects
- Often multiple, wedge-shaped peripheral defects
- May show rapid change on serial imaging
- Usually normal chest X-ray initially
Chronic PE shows:
- Stable perfusion defects over months
- May see evidence of pulmonary hypertension (enlarged central arteries)
- Scarring or pleural changes on chest X-ray
- Right ventricular hypertrophy on ECG
Clinical Scenario
Normal VQ Scan
Uniform symmetrical tracer distribution throughout both lungs. No perfusion defects or areas of mismatch. Normal ventilation-perfusion matching. No evidence of pulmonary hypertension.
Chronic Thromboembolic Disease
Multiple persistent perfusion defects in both lungs with mosaic pattern. Large defect in right upper and middle lobes. Left lung shows smaller peripheral defects. Ventilation relatively preserved. Findings suggest chronic organized thrombi from previous PE.
Clinical Applications
Diagnostic Pathway
The evaluation of suspected CTEPH typically involves:
- Echocardiogram: First test showing pulmonary hypertension
- VQ scan: Screening test to identify chronic thromboembolic disease
- CT pulmonary angiography: Confirmatory test showing organized thrombi
- Right heart catheterization: Measures pulmonary artery pressures
- Multidisciplinary review: Determines operability and treatment plan
Surgical Candidacy Assessment
For potential PTE surgery:
Operable disease:
- Chronic thrombi accessible to surgeon
- Disease predominantly in main, lobar, or segmental arteries
- Adequate pulmonary function
- Acceptable surgical risk
Inoperable disease:
- Thrombi too distal (subsegmental) for surgical access
- Comorbidities making surgery too risky
- Severe right heart failure
- Extensive comorbid lung disease
What Else Could It Be?
Persistent perfusion defects on serial imaging. Mosaic pattern. History of acute PE. Progressive dyspnea. Pulmonary hypertension on echocardiogram.
New or changing perfusion defects on serial imaging. Acute symptom onset. New risk factors. D-dimer elevation.
Normal or mildly abnormal VQ scan. No history of PE. No perfusion defects suggesting thromboembolic disease. Progressive symptoms without acute events.
Stable perfusion defects without progression. Patient not experiencing significant symptoms. No pulmonary hypertension. Stable on serial scans.
Evidence-Based Outcomes
Prognosis and Treatment
Untreated CTEPH has poor prognosis:
- Median survival 1-2 years without treatment
- Progressive right heart failure
- Severe disability and reduced quality of life
With PTE surgery:
- 5-year survival 75-85% in experienced centers
- Significant improvement in symptoms and hemodynamics
- Many patients return to near-normal functional status
With medical therapy (for inoperable disease):
- Vasodilator medications improve symptoms
- Survival at 3-5 years in many patients
- Lung transplantation for eligible patients
Preparing for Your Scan
- Previous PE imaging: Bring all prior scans for comparison
- Recent echocardiogram: Essential for correlation
- Pulmonary function tests: Help assess surgical risk
- Medical history: Provide complete history of PE, treatments, symptoms
Understanding Your Results
What Happens Next?
Confirmatory Imaging
CT pulmonary angiography to precisely map chronic thrombi and assess surgical accessibility. Digital subtraction angiography may be performed.
Hemodynamic Assessment
Right heart catheterization to measure pulmonary artery pressures, cardiac output, and vasoreactivity testing.
Surgical Candidacy Evaluation
CTEPH expert team review to determine if pulmonary thromboendarterectomy is feasible based on clot distribution, patient factors, and comorbidities.
Treatment Planning
PTE surgery if operable, or medical therapy with pulmonary vasodilators and anticoagulation if inoperable.
Frequently Asked Questions
Can chronic PE be cured?
Yes, CTEPH is potentially curable with pulmonary thromboendarterectomy surgery. The operation removes organized chronic clots from pulmonary arteries, with success rates of 75-85% at 5 years in experienced centers.
What if I'm not a surgical candidate?
Patients with inoperable CTEPH can be treated with medical therapy including pulmonary vasodilators (similar to medications used for PAH). Balloon pulmonary angioplasty is also available for some patients. Lung transplantation may be an option for eligible patients.
How is CTEPH different from acute PE?
CTEPH results from chronic, organized blood clots that have been present for months to years. Acute PE consists of fresh clots that may resolve with anticoagulation alone. CTEPH causes pulmonary hypertension and typically requires surgery for cure, while acute PE is managed with blood thinners.
References
- American Heart Association. AHA Guidelines: CTEPH Diagnosis and Treatment. 2024.
- International CTEPH Association. ICTEPH Consensus Guidelines. 2023.
- European Respiratory Journal. CTEPH Diagnosis and Management. 2022.
Medical Disclaimer: This information is educational only. Always discuss findings with your healthcare provider for personalized medical advice.
🔗Explore Related Content
Deepen your understanding with related imaging terms, lab tests, and diseases
Recommended Learning Path
Build comprehensive understanding through structured learning
Have a V/Q Scan Report?
Upload your PDF report for quick plain-language explanations of terms like "Chronic Thromboembolic Disease VQ Scan". WellAlly helps you understand your radiology results.